← Back to Search

Palliative Care consultation outside standard of care for Amyotrophic Lateral Sclerosis

N/A
Waitlist Available
Led By Jocelyn C Zwicker, MD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient with ALS at the Ottawa Hospital ALS clinic or caregiver of participating patient.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months, 12 months, 15 months, 18 months, 21 months after palliative care consultation or study enrollment
Awards & highlights

Study Summary

This trial will investigate whether routine palliative care consultation can improve quality of life for patients and caregivers in an amyotrophic lateral sclerosis (ALS) clinic.

Eligible Conditions
  • Amyotrophic Lateral Sclerosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline compared to 6 month, 12 months, 15 months, 18 months, 21 months after palliative care consult
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline compared to 6 month, 12 months, 15 months, 18 months, 21 months after palliative care consult for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in average Hospital Anxiety and Depression Scale score in caregivers of patients with ALS
Change in average Hospital Anxiety and Depression Scale score in patients with ALS
Difference in average Hospital Anxiety and Depression Scale score for ALS patients between arms
+1 more
Secondary outcome measures
Change in average ALS Specific Quality of Life - Revised score in ALS patients post palliative care
Change in average Hospital Anxiety and Depression Scale score in ALS patients post palliative care
Change in average Hospital Anxiety and Depression Scale score in caregivers of ALS patients post palliative care
+6 more
Other outcome measures
Proportion of patients who complete a palliative care consultation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Early palliative careExperimental Treatment1 Intervention
These patients will receive a palliative care consultation that would not be requested by their care team as standard of care.
Group II: Standard careActive Control1 Intervention
These ALS patients and their caregivers will receive standard care.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
559 Previous Clinical Trials
2,785,486 Total Patients Enrolled
1 Trials studying Amyotrophic Lateral Sclerosis
2 Patients Enrolled for Amyotrophic Lateral Sclerosis
ALS Society of CanadaOTHER_GOV
1 Previous Clinical Trials
84 Total Patients Enrolled
1 Trials studying Amyotrophic Lateral Sclerosis
84 Patients Enrolled for Amyotrophic Lateral Sclerosis
Jocelyn C Zwicker, MDPrincipal InvestigatorThe Ottawa Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~15 spots leftby Mar 2025